Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Anthrax Vaccines

---
identifier: "/us/fr/01-18011"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Anthrax Vaccines"
title_number: 0
title_name: "Federal Register"
section_number: "01-18011"
section_name: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Anthrax Vaccines"
positive_law: false
currency: "2001-07-19"
last_updated: "2001-07-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "01-18011"
document_type: "notice"
publication_date: "2001-07-19"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "66 FR 37656"
fr_volume: 66
fr_action: "Notice."
---


#  Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Anthrax Vaccines

**AGENCY:**

U.S. Army Medical Research and Material Command, DoD.

**ACTION:**

Notice.

**SUMMARY:**

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application Serial No. 09/350,729 entitled “Anthrax Vaccines” and filed July 9, 1999. Foreign rights are also available (PCT/US99/15568). This patent application has been assigned to the United States Government as represented by the Secretary of the Army.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Material Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. Both at telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

Using the nontoxic PA protein from B. anthracis, a method and composition for use in inducing an immune response which is protective against anthrax in subjects is described.

Luz D. Ortiz,

Army Federal Register Liaison Officer.